期刊文献+

经尿道选择性绿激光治疗高龄高危良性前列腺增生症临床分析

A Clinical Analysis of Treatment of Benign Prostatic Hyperplasi Disorder in Senile and High-risk Patients with Transurethral Potassiumtitanylphosphate Laser
下载PDF
导出
摘要 目的:探讨经尿道选择性绿激光治疗高龄高危良性前列腺增生症的安全性、有效性。方法:回顾性分析采用经尿道选择性绿激光术治疗高龄高危良性前列腺增生症患者30例,观察平均手术时间、术后拔管时间、出血量、国际前列腺症状评分(IPSS)、剩余尿量、尿流率变化等指标。结果:30例患者均手术成功,手术时间平均46.3 min,术中出血量平均85.2 mL,术后留置导尿管时间平均24 h,IPSS评分由术前平均21.5分降至术后平均8.3分,最大尿流率由术前平均6.2 mL/s增加到术后平均18.5 mL/s,无1例出现手术相关并发症。结论:经尿道选择性绿激光治疗高龄高危良性前列腺增生症具有手术时间短、出血少、创伤小、恢复快、疗效确切等优点,扩大了高危患者手术的适应证。 Objective: To explore and assess the safety and efficacy of transurethra potassiumtitanylphosphate laser therapy in senile and high-risk patients with benign prostatic hyperplasia disorder.Methods: 30 cases of benign prostate hyperplasia disorder treated with transurethra potassiumtitanylphosphate laser were retrospectively analyzed,examining such indicators as the average operation time,postoperative decannulation time,blood loss,international prostate symptoms score(IPSS),residual urine output and changes in urine flow rate.Results: The operation was a success in all 30 patients,with an average operation time of 46.3 min,an average peri-operative bleeding volume of 85.2 mL,an average postoperative lien time of 1 day,a fall in IPSS From 21.5 points on the average preoperatively to 8.3 points on the average postoperatively and an increase in the urine flow maximum from 6.2 mL/s on the average preoperatively to 18.5 mL/s on the average postoperatively.No surgery-associated complication occurred.Conclusion: Transurethra potassiumtitanylphosphate laser therapy of benign prostatic hyperplasia in senile and high-risk patients has such advantages as short operation time,less bleeding,small trauma,quick recovery,definite effects,etc,and thus can expand surgical indication in high-risk patients.
出处 《包头医学院学报》 CAS 2011年第6期56-57,共2页 Journal of Baotou Medical College
关键词 良性 前列腺增生 高龄高危 绿激光 Benign Prostatichyperplasia Senile High-risk Potassiumtitanylphosphate laser
  • 相关文献

参考文献4

二级参考文献23

  • 1徐月敏,张炯,金重睿,撒应龙,张心如,陈嵘,谢弘,李涛,司捷旻.KTP激光汽化术治疗良性前列腺增生[J].中华泌尿外科杂志,2004,25(9):631-633. 被引量:85
  • 2洪宝发,蔡伟,符伟军,杨勇,王威,陈耀富,展洁,张翠娥,李炎唐,崔胜堂.选择性绿激光汽化术治疗良性前列腺增生的临床研究[J].中华泌尿外科杂志,2005,26(1):17-19. 被引量:90
  • 3Uchida T,Ohori M,Soh S,et al.Factors influencing morbidity in patients undergoing transurethral resection of the prostate.Urology,1999 ,53:98-105.
  • 4Anson K.Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only? Curr Opin Urol,2004,14:27-29.
  • 5Shingleton WB,Terrell F,Renfroe L,et al.Low-power vs high-power KTP laser:improved method of laser ablation of prostate.J Endourol,1999,13:49-52.
  • 6Hai MA,Malek RS.Photoselective vaporization of the prostate :initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia.J Endourol,2003 ,17 :93-96.
  • 7Reich O,Bachmann A,Schneede P,et al.Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate.J Urol,2004,171 (6 Pt1) :2502-2504.
  • 8Malek RS,Kuntzman RS,Barrett DM.High power potassium-titanyl-phosphate laser vaporization prostatectomy.J Urol,2000,163:1730-1733.
  • 9Te AE,Malloy TR,Stein BS,et al.Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia:12-month results from the first United States multicenter prospective trial.J Urol,2004,172(4 Pt 1) :1404-1408.
  • 10Larson TR.Current treatment options for benign prostatic hyperplasia and their impact on sexual function.Urology ,2003,61:692-698.

共引文献203

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部